Quest's "HCV RNA QUALITATATIVE TMA" written on the report form as " HCV RNA QUAL TMA". As it's name suggests it's a qualitative and goes down to 5 IU/ml, the same sensitivity as Heptimax. At this point, you don't need numbers, just need to know whether you're UND. Regardless of where the blood is drawn, the test is only run at the Nichol's Institute at Cupertino, CA, which supposedly has the highest standards.
thanks, but I'm still confused. what is the difference between quan and qual tests?
mine have always said RNA Quant RT PCR.
and why did someone say "The Heptimax is a 2 part TMA not a PCR. I am looking for a PCR that only measures actual RNA without including dead virus particles".
Is a Heptimax and the Quanta Sure the same as the <43 VL test, just more sensitive?
I don't see the concern with dead particles. Quantatative measures the amount of any HCV RNA virus in serum to the upper limit or sensitivity of the test. Qualitatative determines only the presence of HCV RNA in serum to the upper limit of the test. Absence of detectable HCV RNA in serum including dead particles is still UND. With your RVR I would not be overly concerned other than to confirm you are UND. If it were me, I would be comfortable with the Labcorp <43 but it's your EOT PCR so you should do whatever you're comfortable with.
In regards to TMA vs PCR, you might find the below article of interest:
Hepatology. 2000 Oct;32(4 Pt 1):818-23.
"Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays." Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S.
Medizinische Klinik II, J.W. Goethe-University, Frankfurt am Main, Germany.
"A considerable proportion of patients with chronic hepatitis C who achieve a virologic end-of-treatment response relapse after discontinuation of therapy. It is conceivable that polymerase chain reaction (PCR)-based assays with a lower detection limit of 100 to 1, 000 hepatitic C virus (HCV) RNA copies/mL are still too insensitive to detect residual viremia. End-of-treatment serum samples of 47 patients with a virologic relapse according to results of qualitative PCR assays (Amplicor HCV; Roche Molecular Systems, Mannheim, Germany) were tested by transcription-mediated amplification (TMA), an isothermal, autocatalytic target amplification method that has the potential to detect less than 50 HCV RNA copies/mL. Virologic sustained responders (n = 59) and nonresponders (n = 49) served as controls. In end-of-treatment serum samples of virologic sustained responders and nonresponders an almost complete concordance between PCR and TMA results was observed (98%). However, HCV RNA was detectable by TMA in end-of-treatment serum samples from 16 of 25 relapse patients (64%) who were HCV-RNA-negative according to Amplicor HCV version 1.0 (lower detection limit 1,000 copies/mL) and in 8 of 22 patients (36%) who were HCV-RNA-negative according to Amplicor HCV version 2.0 (lower detection limit 100 copies/mL). End-of-treatment alanine transaminase (ALT) levels of sustained virologic responders and TMA-negative relapsers were similar, whereas a trend toward higher ALT values was observed in TMA-positive relapsers compared with sustained virologic responders (P = 0.09). In conclusion, HCV RNA can be detected at the end of treatment by TMA in a considerable proportion of patients who were classified as virologic end-of-treatment responders with a subsequent virologic relapse according to PCR-based methods."
Qualitative viral load tests — These tests determine the presence of HCV RNA in the blood. This type of test is usually used to confirm chronic infection with HCV. If viral RNA is detected, a positive result is reported; if viral RNA is not detected, the test result is negative.
Quantitative viral load tests — These tests measure the amount of virus in one milliliter of blood. They are often used to assess whether or not treatment with interferon or interferon plus ribavirin is likely to be successful and, later, if treatment is working.
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.